The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study
Abstract
The frequency of antibiotic-associated diarrhoea (AAD) and Clostridium difficile-associated diarrhoea (CdAD) was prospectively determined in a population of 2462 patients recruited from five Swedish hospitals, including divisions for infectious diseases, orthopaedics, surgery, geriatrics, nephrology and internal medicine. AAD developed in 4.9% of the treated patients. Faecal samples were obtained from 69% of patients with AAD and 55.4% were positive for C. difficile cytotoxin B. The frequency of AAD varied from 1.8 to 6.9% at the participating centres (P < 0.001). The frequency of AAD also varied considerably between medical disciplines and wards within different hospitals and was highest in the nephrology and geriatric units (6.7 and 7.1%, respectively). There was no difference in frequency of AAD when analysed with respect to gender or age. Medical interventions (laxative treatment, endoscopy and abdominal surgery) or presence of one concomitant disease (diabetes, malignancy, chronic renal disease and inflammatory bowel disease) did not significantly affect the frequency of AAD, whereas patients suffering from two or more of these illnesses had significantly (P = 0.001) higher frequencies of AAD. Patients treated with antibiotics for 3 days had a significantly (P = 0.009) lower frequency of AAD than those treated for longer periods. Treatment with cephalosporins, clindamycin or broad-spectrum penicillins was associated with an increased risk of AAD. With specimens from one centre, 62.5% of tested patients with AAD and 33.8% of asymptomatic patients were positive for cytotoxin B. Although C. difficile cytotoxin B in stool samples was significantly associated with AAD (P = 0.003), the causal relationship with diarrhoea is not always evident.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nosocomial Acquisition of Clostridium difficile Infection
McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., & Stamm, W. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200402 · Cited by 1,326
Risk factors for Clostridium difficile infection
Bignardi, G. E. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90019-6 · Cited by 647
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
Surawicz, C. M., Elmer, G. W., Speelman, P., McFarland, L. V., Chinn, J., & Van Belle, G. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91613-2 · Cited by 573
Clabots, C. R., Johnson, S., Olson, M. M., Peterson, L. R., & Gerding, D. N. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.3.561 · Cited by 476
McFarland, L. V., Surawicz, C. M., & Stamm, W. E. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.3.678 · Cited by 378
Mechanisms and Management of Antibiotic‐Associated Diarrhea
Hogenauer, C., Hammer, H. F., Krejs, G. J., & Reisinger, E. C. (1998) · Clinical Infectious Diseases · doi:10.1086/514958 · Cited by 348
Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W., Moyer, K. A., Melcher, S. A., Bowen, K., & Cox, J. L. (1995) · PubMed · Cited by 338
Clostridium difficile Colonization and Diarrhea at a Tertiary Care Hospital
Samore, M. H., DeGirolami, P. C., Tlucko, A., Lichtenberg, D. A., Melvin, Z. A., & Karchmer, A. W. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.181 · Cited by 251
Aronsson, B., Mollby, R., & Nord, C. E. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.3.476 · Cited by 245
Financial burden of hospital-acquired Clostridium difficile infection
Wilcox, M. H., Cunniffe, J. G., Trundle, C., & Redpath, C. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90122-x · Cited by 244
Decrease in Nosocomial Clostridium difficile–Associated Diarrhea by Restricting Clindamycin Use
Pear, S. M., Williamson, T. H., Bettin, K. M., Gerding, D. N., & Galgiani, J. N. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-4-199402150-00003 · Cited by 235
A Prospective Nationwide Study of Clostridium difficile‐Associated Diarrhea in Sweden
Karlström, O. H., Fryklund, B. A., Tullus, K., BURMAN, L. G., & the Swedish C. difficile Study Group (1998) · Clinical Infectious Diseases · doi:10.1086/516277 · Cited by 177
Lewis, S. J., Potts, L. F., & Barry, R. E. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)80008-x · Cited by 171
Clinical impact and associated costs of Clostridium difficile- associated disease
Spencer, R. C. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.suppl_3.5 · Cited by 127
Infection Due to Clostridium difficile Among Elderly Residents of a Long-Term-Care Facility
Simor, A. E., Yake, S. L., & Tsimidis, K. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.672 · Cited by 127
The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease
Spencer, R. C. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.suppl_3.21 · Cited by 121
Intestinal colonization withClostridium difficile in infants up to 18 months of age
Tullus, K., Aronsson, B., Marcus, S., & Möllby, R. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01964052 · Cited by 109
Orrhage, K., Brismar, B., & Nord, C. E. (1994) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v7i1.8155 · Cited by 104
The epidemiology and typing of Clostridium difficile
Brazier, J. S. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.suppl_3.47 · Cited by 101
Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas
Bartlett, J. G. (1996) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199611000-00005 · Cited by 58
Edlund, C., Stark, C., & Nord, C. E. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.1.127 · Cited by 51
Chachaty, É., Depitre, C., Mario, N., Bourneix, C., Saulnier, P., Corthier, G., & Andremont, A. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.2009 · Cited by 43
Clostridium difficile and antibiotic associated diarrhoea in Sweden.
Aronsson, B., Möllby, R., & Ce, N. (1982) · PubMed · Cited by 38
Medical Implications of Nosocomial Infection with Clostridium difficile
Eriksson, S., & Aronsson, B. (1989) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548909021705 · Cited by 35
Cited by
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
Suez, J., Zmora, N., Zilberman-Schapira, G., Mor, U., Dori-Bachash, M., Bashiardes, S., Zur, M., Regev-Lehavi, D., Ben-Zeev Brik, R., Federici, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.047 · Cited by 1,184
Antibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197
Gavazzi, G., & Krause, K.-H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00437-1 · Cited by 990
The Changing Epidemiology of Clostridium difficile Infections
Freeman, J., Bauer, M. P., Baines, S. D., Corver, J., Fawley, W. N., Goorhuis, B., Kuijper, E. J., & Wilcox, M. H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00082-09 · Cited by 826
Metadata
- Authors
- Wistrom, J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01-01
- Volume
- 47
- Issue
- 1
- Pages
- 43-50
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2097867359
- Cited by
- 448
- References
- 24
- FWCI
- 12.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.